Phibro Animal Health Corporation and Zydus Cadila today announced their intention to enter into a long-term arrangement to license Phibro’s innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Zydus Cadila to serve the fast growing poultry market in India.
Jack Bendheim, Chairman, President and Chief Executive Officer of Phibro, remarked, “We are proud of the more than 20-year partnership with Zydus Cadila serving the Indian animal health market and we view this as an exciting next step in our relationship.”
Speaking on the development Mr. Pankaj R. Patel, Chairman and Managing Director, Zydus group said, “Our endeavour has always been to enable access to innovative therapies across geographies and this agreement with Phibro will help bring innovations to the poultry market in India. The availability of new advanced poultry vaccines, which were until now being imported into India, adds a new dimension to the Make-in-India movement in the animal health segment.”